Recombinant KRT20 antibody (AA 196-323)
Quick Overview for Recombinant KRT20 antibody (AA 196-323) (ABIN7871711)
Target
See all KRT20 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 196-323
-
Purpose
- Recombinant Keratin 20 Antibody / CK20 / Cytokeratin 20
-
Purification
- Protein A/G affinity
-
Immunogen
- A portion of amino acids 196-323 was used as the immunogen for the recombinant Keratin 20 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- Optimal dilution of the recombinant Keratin 20 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the recombinant Keratin 20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- KRT20 (Keratin 20 (KRT20))
-
Alternative Name
- Keratin 20
-
Background
- This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.
-
UniProt
- P35900
Target
-